BEIJING, June 4, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that the independent committee of the Company's board of directors (the "Independent Committee") has appointed Lazard and Houlihan Lokey as its independent financial advisors.
